{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:26:24Z","timestamp":1781756784996,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.05.041","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T20:15:21Z","timestamp":1466021721000},"page":"3840-3847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Emma J.","family":"Best","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Souter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Neeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Salkeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahoor","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1473-3099(10)70012-8","article-title":"Otitis media and its consequences: beyond the earache","volume":"10","author":"Vergison","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.05.041_b0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijporl.2013.11.030","article-title":"Acute otitis media in young children \u2013 what do parents say?","volume":"78","author":"Barber","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1473-3099(13)70338-4","article-title":"Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3\u20134 trial","volume":"14","author":"Palmu","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2016.05.041_b0020","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/INF.0000000000000857","article-title":"Effectiveness of the ten-valent pneumococcal conjugate vaccine against tympanostomy tube placements in a cluster-randomized trial","volume":"34","author":"Palmu","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.041_b0025","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1086\/525856","article-title":"Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media","volume":"46","author":"Revai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.05.041_b0030","first-page":"CD001480","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","volume":"4","author":"Fortanier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2016.05.041_b0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/INF.0b013e31819e9bc5","article-title":"The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia","volume":"28","author":"Jardine","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.041_b0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.041_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.041_b0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine","volume":"29","author":"Casey","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2016.05.041_b0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.inf.0000136868.91756.80","article-title":"Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media","volume":"23","author":"Block","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2016.05.041_b0060","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/cid\/cis292","article-title":"Impact of pneumococcal conjugate vaccination on otitis media: a systematic review","volume":"54","author":"Taylor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.05.041_b0065","unstructured":"Heffernan H, Roos R. Invasive pneumococcal disease in New Zealand, 2014. Institute of Environmental Science and Research Ltd (ESR) Porirua: ESR; 2016. <https:\/\/surv.esr.cri.nz\/surveillance\/IPD.php?we_objectID=4316> [accessed April 2016]."},{"issue":"1378","key":"10.1016\/j.vaccine.2016.05.041_b0070","first-page":"26","article-title":"Impact of pneumococcal vaccine on hospital admission with lower respiratory infection in children resident in South Auckland, New Zealand","volume":"126","author":"Vogel","year":"2013","journal-title":"N Z Med J"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/jpc.12710","article-title":"What is behind the ear drum? the microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination","volume":"51","author":"Mills","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2016.05.041_b0080","unstructured":"Ministry of health. Immunisation handbook 2011. Wellington: Ministry of Health; 2011. <http:\/\/www.health.govt.nz\/publication\/immunisation-handbook-2011>. 978-0-478-37457-5 (print), 978-0-478-37458-2 (online)."},{"issue":"9512","key":"10.1016\/j.vaccine.2016.05.041_b0085","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0090","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial","volume":"56","author":"van den Bergh","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.041_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vaccine.2009.09.113","article-title":"Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age","volume":"28","author":"Prymula","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.041_b0100","unstructured":"Ministry of health. Ethnicity data protocols for the health and disability sector. Wellington: Ministry of Health; 2004. <https:\/\/www.health.govt.nz\/system\/files\/documents\/publications\/ethnicitydataprotocols.pdf> [accessed 20th January 2016]."},{"key":"10.1016\/j.vaccine.2016.05.041_b0105","series-title":"Clinical laboratory standards institute \u2013 performance and standards for antimicrobial susceptibility testing \u2013 approved standard","year":"2009"},{"issue":"8","key":"10.1016\/j.vaccine.2016.05.041_b0110","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho Mda","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.041_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6815-6-10","article-title":"Measuring nasal bacterial load and its association with otitis media","volume":"6","author":"Smith-Vaughan","year":"2006","journal-title":"BMC Ear Nose Throat Disord"},{"issue":"4","key":"10.1016\/j.vaccine.2016.05.041_b0120","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/JCM.41.4.1386-1390.2003","article-title":"Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR","volume":"41","author":"Greiner","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0125","doi-asserted-by":"crossref","first-page":"e34083","DOI":"10.1371\/journal.pone.0034083","article-title":"Molecular surveillance of true nontypeable Haemophilus influenzae: An evaluation of PCR screening assays","volume":"7","author":"Binks","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2016.05.041_b0130","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1128\/JCM.02509-10","article-title":"Use of bexB to detect the capsule locus in Haemophilus influenzae","volume":"49","author":"Davis","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"1022","key":"10.1016\/j.vaccine.2016.05.041_b0135","first-page":"182","article-title":"The microbiology of chronic otitis media with effusion in a group of Auckland children","volume":"109","author":"Watson","year":"1996","journal-title":"N Z Med J"},{"issue":"5","key":"10.1016\/j.vaccine.2016.05.041_b0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3346\/jkms.2004.19.5.735","article-title":"Detection rates of bacteria in chronic otitis media with effusion in children","volume":"19","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2016.05.041_b0145","unstructured":"R Core Team. R: A language and environment for statistical computing. R foundation for statistical computing."},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.041_b0150","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in finnish children \u2013 a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.041_b0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.vaccine.2016.05.041_b0160","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2016.05.041_b0165","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1016\/j.vaccine.2012.08.017","article-title":"Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and\/or PHiD-CV in the province of Quebec, Canada","volume":"30","author":"De Wals","year":"2012","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2016.05.041_b0170","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.041_b0175","doi-asserted-by":"crossref","first-page":"e1001657","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young latin American children: a double-blind randomized controlled trial","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.vaccine.2016.05.041_b0180","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/INF.0000000000000899","article-title":"Decreased incidence of respiratory Infections in children after vaccination with ten-valent pneumococcal vaccine","volume":"34","author":"Sigurdsson","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.041_b0185","doi-asserted-by":"crossref","first-page":"e85459","DOI":"10.1371\/journal.pone.0085459","article-title":"Immunogenicity, impact on carriage and reactogenicity of 10-Valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1\u20134years: randomized controlled trial","volume":"9","author":"Hammitt","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2016.05.041_b0190","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/JCM.00566-12","article-title":"Culture and PCR detection of Haemophilus influenzae and Haemophilus haemolyticus in Australian indigenous children with bronchiectasis","volume":"50","author":"Hare","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.041_b0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-015-1857-x","article-title":"Haemophilus influenzae: using comparative genomics to accurately identify a highly recombinogenic human pathogen","volume":"16","author":"Price","year":"2015","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.vaccine.2016.05.041_b0200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/CVI.00632-13","article-title":"Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae","volume":"21","author":"Smith-Vaughan","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2016.05.041_b0205","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2016.05.041_b0210","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2016.05.041_b0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.05.041_b0220","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.05.041_b0225","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.041_b0230","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ng.2625","article-title":"Population genomics of post-vaccine changes in pneumococcal epidemiology","volume":"45","author":"Croucher","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.05.041_b0235","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007151","article-title":"Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study","volume":"5","author":"Groth","year":"2015","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.vaccine.2016.05.041_b0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003807","article-title":"Inequalities in ventilation tube insertion procedures between aboriginal and non-Aboriginal children in New South Wales, Australia: a data linkage study","volume":"3","author":"Falster","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.041_b0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007247","article-title":"Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial","volume":"5","author":"Leach","year":"2015","journal-title":"BMJ Open"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T19:52:01Z","timestamp":1656705121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":49,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X1630367X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}